CD4+ T Cell Regulation of CD25 Expression Controls Development of Short-Lived Effector CD8+ T Cells in Primary and Secondary Responses by Obar, Joshua J et al.
Dartmouth College
Dartmouth Digital Commons
Open Dartmouth: Faculty Open Access Articles
1-5-2010
CD4+ T Cell Regulation of CD25 Expression
Controls Development of Short-Lived Effector
CD8+ T Cells in Primary and Secondary
Responses
Joshua J. Obar
University of Connecticut Health Center
Michael J. Molloy
Dartmouth College
Evan R. Jellison
University of Connecticut Health Center
Thomas A. Stoklasek
University of Connecticut Health Center
Weijun Zhang
Dartmouth College
See next page for additional authors
Follow this and additional works at: https://digitalcommons.dartmouth.edu/facoa
Part of the Medical Immunology Commons
This Article is brought to you for free and open access by Dartmouth Digital Commons. It has been accepted for inclusion in Open Dartmouth: Faculty
Open Access Articles by an authorized administrator of Dartmouth Digital Commons. For more information, please contact
dartmouthdigitalcommons@groups.dartmouth.edu.
Recommended Citation
Obar, Joshua J.; Molloy, Michael J.; Jellison, Evan R.; Stoklasek, Thomas A.; Zhang, Weijun; Usherwood, Edward J.; and Lefrançois,
Leo, "CD4+ T Cell Regulation of CD25 Expression Controls Development of Short-Lived Effector CD8+ T Cells in Primary and
Secondary Responses" (2010). Open Dartmouth: Faculty Open Access Articles. 1484.
https://digitalcommons.dartmouth.edu/facoa/1484
Authors
Joshua J. Obar, Michael J. Molloy, Evan R. Jellison, Thomas A. Stoklasek, Weijun Zhang, Edward J.
Usherwood, and Leo Lefrançois
This article is available at Dartmouth Digital Commons: https://digitalcommons.dartmouth.edu/facoa/1484
CD4+ T cell regulation of CD25 expression controls
development of short-lived effector CD8+ T cells in
primary and secondary responses
Joshua J. Obara,1, Michael J. Molloyb,1, Evan R. Jellisona, Thomas A. Stoklaseka, Weijun Zhangb,
Edward J. Usherwoodb,2, and Leo Lefrançoisa,2
aDepartment of Immunology, University of Connecticut Health Center, Farmington CT 06030; and bDepartment of Microbiology and Immunology, Dartmouth
Medical School, Lebanon NH 03756
Edited by Douglas T. Fearon, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom, and approved November 5, 2009 (received for
review September 4, 2009)
Both CD4+ T cell help and IL-2 have been postulated to “program”
activated CD8+ T cells for memory cell development. However, the
linkage between these two signals has not been well elucidated.
Here we have studied effector and memory CD8+ T cell differen-
tiation following infection with three pathogens (Listeria mono-
cytogenes, vesicular stomatitisvirus, andvacciniavirus) in theabsence
of both CD4+ T cells and IL-2 signaling. We found that expression of
CD25 on antigen-specific CD8+ T cells peaked 3–4 days after initial
priming and was dependent on CD4+ T cell help, likely through a
CD28:CD80/86 mediated pathway. CD4+ T cell or CD25-deficiency
led to normal early effector CD8+ T cell differentiation, but a subse-
quent lack of accumulation of CD8+ T cells resulting in overall de-
creased memory cell generation. Interestingly, in both primary and
recall responses KLRG1high CD127low short-lived effector cells were
drastically diminished in theabsence of IL-2 signaling, althoughmem-
ory precursors remained intact. In contrast to previous reports, upon
secondary antigen encounter CD25-deficient CD8+ T cells were capa-
ble ofundergoing robust expansion, but short-lived effectordevelop-
mentwasagain impaired.Thus, these results demonstrated thatCD4+
T cell help and IL-2 signaling were linked via CD25 up-regulation,
which controls the expansion and differentiation of antigen-specific
effector CD8+ T cells, rather than “programming”memory cell traits.
infection | memory
Although recent findings have advanced our knowledge of thefactors necessary to generate optimal memory CD8+ T cell
responses, a full understanding of the signals required remains
elusive. CD8+ T cell responses to acute viral or bacterial in-
fections are characterized by three phases. Upon recognition of a
specific antigenic epitope, T cells undergo massive proliferation
and acquisition of effector functions. Pathogen-specific CD8+ T
cells can expand close to 105-fold from a population as small as a
few hundred precursors (1). These effector T cells have altered
chemokine and homing receptor expression enabling their mi-
gration through all peripheral tissues (2, 3). On further antigenic
stimulation, the effector CD8+ T cells will kill infected target
cells through several mechanisms thereby limiting pathogen
growth and dissemination. After this stage, effector CD8+ T cells
enter a contraction phase where a majority of the effector cells
undergo apoptosis leaving only 5–20% of the cells present at the
peak of expansion (4). The last stage is characterized by the
maintenance of a heterogeneous population of long-lived, stable
CD8+ memory T cells (5). These remaining cells are charac-
terized as stem-cell like because they retain telomerase ex-
pression, the ability to self-renew, a high proliferative capacity,
and multipotency (5). In acute infections, the persistence of
these memory T cells relies on the presence of the common
gamma-chain (γc) cytokines IL-7 and IL-15 (6, 7). Upon secon-
dary exposure to the specific antigen, memory CD8+ T cells
undergo a more rapid expansion and production of effector cy-
tokines compared to the primary response, which results in rapid
control of infection.
Unfortunately, these cardinal rules of memory CD8+ T cell
function do not account for the extensive functional and pheno-
typic complexity of subsets that is known to exist (5). Additionally,
exactly when each subset differentiates from the original naïve
precursor remains controversial (8). Recent work has demon-
strated that a single naïve antigen-specificCD8+T cell can give rise
to all of the effector andmemory subsets observed (9). One theory
suggests that heterogeneity occurs as early as the first asymmetric
division of a naïve cell, where one daughter cell is “fated” to be-
come effector-like through the up-regulation of effectormolecules
and expression of differentiation markers. Meanwhile, the sister
cell retains the ability to differentiate into a memory-like cell (10).
It is unclear whether these lineages are set in stone or whether
manipulation of cell fate can occur through the presence or lack of
secondary stimulation. Recent evidence indicates the latter sce-
nario is likely true because cells that have up-regulated granzymeB
(and therefore would be considered effector-like) maintained the
ability to form long-lived memory cells (11).
Population heterogeneity continues throughout the expansion
phase, as the ability to form memory cells can be correlated with
the expression patterns of CD127 and the killer cell lectin-like
receptor G1 (KLRG1) (12–14). Briefly, KLRG1high CD127low
CD8+ T cells are considered to be more terminally differentiated
and die after clearance of the infection and therefore are re-
ferred to as short-lived effector cells (SLEC). KLRG1low
CD127high CD8+ T cells are referred to as memory precursor
effector cells (MPEC) because they possess effector properties,
but retain the ability to differentiate into a long-lived memory
population. The factors regulating the formation of the SLEC
and MPEC populations remain ill-defined. It is well established
that three signals are necessary for the activation of naïve CD8+
T cells: (i) TCR stimulation, (ii) costimulation, and (iii) in-
flammatory cytokines (15), but how variations in these signals
may orchestrate effector and memory heterogeneity is not clear.
Interestingly, alterations in the amount of antigenic exposure do
not seem to skew effector cell differentiation, but the inflammatory
milieu is able to alter the SLEC/MPEC ratio (12, 14, 16).
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Based upon this, we explored whether other known regulators of
effector and memory CD8+ T cell differentiation, namely CD4+ T
cell help and IL-2 signaling, are critical for the development of
SLEC and MPEC populations.
Costimulatory signals driven byCD4+T cells have been shown to
be crucial for the optimal differentiationofmemoryCD8+T cells in
various models (17–19). However, controversy remains as to pre-
cisely when CD4+ T cell help is required for memory CD8+ T cell
differentiation. Depending on a number of variables in different
infection models, CD4+ T cells are required during priming,
maintenance, or recall and, in some cases, CD4+ T cell help can be
nonessential (17–21). An important variable that alters the re-
quirement for CD4+ T cell help is the pathogen that is under study.
For example, the CD8+ T cell response to vesicular stomatitis virus
(VSV) infection is largely independent of CD4+ T cell help. In the
case of the CD8+ T cell response to Listeria monocytogenes (LM)
infection, some reports indicate a CD4+ T cell requirement for
primary expansion (21, 22) although others do not (18, 19). How-
ever, even when CD4+ T cell help is apparently not required for
primary expansion, the “helpless” memory CD8+ T cells respond
poorly to challenge (17–19), but there is disagreement in the liter-
ature on this point (21, 22). Additionally, in the absence of CD4+ T
cell help, immune responses to intranasal infection with vaccinia
virus-WesternReserve (VV-WR)ormurine γ-herpesvirus generate
normal primary responses, but secondary recall is inhibited through
theup-regulationof PD-1 (23).Although the critical signal provided
by CD4+ T cell help appears to be the ligation of CD40 on antigen
presenting cells, IL-2 production by CD4+ T cells may also play a
role (24–26). Additionally, previous studies indicate that CD4+ T
cell help and IL-2 signaling during priming, although not shown to
be synonymous, are not required for the primary CD8+ T cell re-
sponse to infectionbutare essential for the formationofa functional
memory population (27, 28). Nonetheless, themechanism by which
CD4+ T cells impinge on CD8+ effector and memory T cell subset
development remains unclear.
The results presented here demonstrated that optimal differ-
entiation of the SLEC population during primary and secondary
CD8+ T cell responses required the expression of CD25 and that
CD4+ T cell help, possibly through CD28 costimulation, regulated
theexpressionofCD25on thepathogen-specificCD8+Tcells.Thus,
the helpless condition or the absence of CD25 resulted in a marked
reduction of the primary CD8+ T cell response that was largely re-
stricted to theSLECsubset.However, the resultingmemoryCD8+T
cells readily responded to secondary challenge. Our findings sup-
ported a role for CD4+ T cells in promoting IL-2 driven effector
CD8+ T cell expansion and survival, but do not support the notion
that these factors affect the functionality of memory CD8+ T cells.
Results
CD4+ T Cell Help Is Critical for the Up-Regulation of CD25 by Antigen-
Specific CD8+ T Cells.Wewished to test whether a link exists between
CD4+Tcell help andCD25expression byCD8+Tcells. Toaccount
for potential variability between different systems, we examined
responses to LM or VSV expressing ovalbumin (LM-ova; VSV-
ova), and VV-WR. C57BL/6 CD8+ T cells up-regulated CD25
transiently with peak expression at approximately 4 days after in-
fection regardless of the pathogen studied (Fig. 1A and B). In
contrast, pathogen-specific CD8+ T cells in mice treated with anti-
CD4 mAb or in MHC class II−/− mice only weakly up-regulated
CD25 (Fig. 1 A and B and Fig. S1). As past studies have shown that
CD40 deficient mice have similar responses to helpless mice and
agonistic anti-CD40 antibodies can substitute for CD4+ T cell help,
we tested whether CD40−/− mice lacked the ability to up-regulate
CD25 (25, 29). Surprisingly, VV-specific CD8+ T cells fromCD40-
deficient animals expressed high levels of CD25, indistinguishable
from those in normal mice (Fig. 1C). In contrast, only minimal up-
regulation of CD25 was observed in CD8+T cells from both CD28-
deficient and CD80/86-deficient mice (Fig. 1C). The decreased
CD25 expression could be a direct result of CD28:CD80/86 signals
but might also be a consequence of decreased IL-2 production be-
cause CD28:CD80/86 signals are known to regulate IL-2 expression
which in turn can regulate CD25 expression (30). To test this hy-
pothesis, helpless mice were treated with 15,000U of rhIL-2 twice a
day and subsequently CD25 expression on day 4 after VV infection
was determined. Interestingly, rhIL-2 treatment was able to restore
CD25 expression by VV-specific CD8+ T cells (Fig. S2). Thus,
CD4+ T cell help plays an important role in regulating the ex-
pression of CD25 on pathogen-specific CD8+ T cells during in-
fection potentially through CD28-CD80/86 mediated expression of
IL-2 from CD4+ T cells.
CD25 Expression Is Necessary for Optimal Expansion of CD8+ T Cells.
As helpless CD8+ T cells were unable to up-regulate CD25, we
examined whether primary responses were compromised in anti-
CD4 mAb treated mice. Following infection, antigen-specific
CD8+ T cells from all groups of mice underwent an initial robust
expansion, but responding CD8+ T cells from LM-ova and VV-
WR infected anti-CD4 mAb treated hosts were unable to sustain
expansion (Fig. 2 A and B). In contrast, CD4-depleted VSV-ova
infected mice mounted a primary response equivalent to that of
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Fig. 1. CD4+ T cell help is required for the expression of CD25 by antigen-
specific CD8+ T cells. (A) Time-course showing the percentage of B8R/Kb-
specific CD8+ T cells expressing CD25 for mice infected with VV-WR in the
presence (blue) or absence (red) of CD4+ T cells for 7 days p.i. (B) Repre-
sentative histograms show the peak expression of CD25 following infection
with VV-WR, LM-ova, or VSV-ova in the presence (blue line) or absence (red
line) of CD4+ T cells. Shaded histograms = isotype control. (C) Representative
histograms and time-course showing CD25 expression on B8R/Kb-specific
CD8+ T cells from intact (blue) or CD4-depleted WT mice (red), CD40−/− mice
(black), CD28−/− mice (green), or CD80/86−/− mice (orange) four days p.i.
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intact mice (Fig. 2C), confirming previous studies (21). CD8+ T
cells in MHC class II−/− mice exhibited a similar phenomenon to
CD4-depleted mice in all cases (Fig. S1). Interestingly, optimal
expansion of VV-specific CD8+ T cells correlated with con-
ditions that resulted in high levels of CD25 expression (Fig. S3).
To determine whether expression of CD25 was responsible for
the disparity between responses to different infections, we gen-
erated C57BL/6:CD25−/− mixed bone marrow chimeras as pre-
viously described (27, 28). The generation of mixed bone marrow
chimeras is necessary as CD25−/− mice develop autoimmunity and
lymphoproliferative disease at an early age due to the absence of
regulatory T cells (31). Chimeric mice were infected with LM-ova
or VV-WR and a kinetic analysis of peripheral-blood pathogen-
specific CD8+T cells was conducted. Although both populations of
CD8+T cells expanded equivalently through days 4–6, theCD25−/−
cells failed to undergo sustained expansion and were rapidly out-
numbered by the WT cells in all cases (Fig. 3 A and B), which is in
contrast to previously published reports (27, 28). A similar disparity
between the expansion of C57BL/6 cells and CD25−/− cells at the
peak of the LM-ova CD8+ T cell response was also observed in
lymphoid and peripheral tissues of infected mice, indicating that
this effect was not isolated to the peripheral blood (Fig. S4). Fol-
lowing VSV infection, the decreased response of CD25−/− cells was
substantially less severe than that observed for LM-ova and VV-
WR infection (Fig. S5). Nevertheless, SLEC development was
impaired, but because fewer SLEC developed after VSV infection
compared to LM infection, the overall response was less affected.
To examine whether the observations in the helpless mice and
CD25-deficient cells were linked, we treated mixed chimeras with
CD4 depleting antibody. When CD4+ T cells were depleted from
chimeric mice infected with LM-ova, no statistical difference in
the percentage of Ova/Kb-specific cells was observed between
CD4-deficient WT and CD25−/− cell populations (Fig. 3A). Sim-
ilar results were observed for anti-CD4 treated VV-WR infected
chimeras during the expansion phase; however during the early
stages of the memory phase, a small but statistically significant
difference between the percentage of B8R-specific WT and
CD25−/− CD8+ T cells in CD4-depleted mice was observed (Fig.
3B). Overall, these results suggested that decreased IL-2 signaling
in helpless mice, as a result of lower CD25 levels, was responsible
for the reduced accumulation of pathogen-specific CD8+ T cells.
Short-Lived Effector CD8+ T Cell Differentiation Is Regulated by IL-2.
Wenext examined the role of IL-2 signaling in development of the
SLEC andMPEC populations. Expression of CD25 on SLEC and
MPEC Ova/Kb-specific CD8+ T cells was analyzed five days after
LM-ova infection. Furthermore, a third effector CD8+ T cell
population was observed at this time point, which was KLRG1low
CD127low [herein termed “early effector cells” (EEC)]. CD25
expression was greatest on the EEC subpopulation, with inter-
mediate expression levels in the SLEC population, and theMPEC
population expressing the lowest CD25 levels (Fig. S6). Therefore,
we tested whether CD25-deficiency affected the expansion of a
particular effector cell subpopulation after LM-ova or VV-WR
infection. Interestingly, before the peak of the responses (days 6/7)
effector cell differentiation was similar between WT and CD25-
deficient CD8+ T cells. However, by the peak of the CD8+ T cell
response WT cells were predominantly found to have a SLEC
phenotype (KLRG1high CD127low), although CD25−/− pathogen-
specific CD8+ T cells failed to accumulate the SLEC population
and had increased frequencies of EEC and MPEC populations
(Fig. 4 A–C and Fig. S7). Furthermore, the subset skewing of the
antigen-specific CD25−/− was maintained into the early memory
stages. Thus, although IL-2 signaling affected the overall ex-
pansion and survival of the responding CD8+ T cells, it appeared
that IL-2 was most critical for differentiation and expansion of the
SLEC subset.
IL-2 Drives Maximal Proliferation of Effector Cells Late in the
Response. To determine the reason for the impairment of
CD25−/− CD8+ T cells we measured cell proliferation by BrdU
incorporation.Mixed bonemarrow chimeras (WT:CD25−/−) were
infected with LM-ova and the mice were treated with BrdU on
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Fig. 2. Early and late expansion of pathogen-specific CD8+ T cells in helpless mice. C57BL/6 mice were either treated with anti-CD4 or left untreated. Mice were
subsequently infectedwith103CFUofLm-ova (A), 2×106PFUofVV-WR(B), or105PFUofVSV-ova (C) and tetramer+splenicCD8+T cellsweremonitored. Thesedata
are representative of two independent experiments, each containing four to five mice per group. Statistical significance was determined using a Student's t test.
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Fig. 3. CD25-mediated signals are necessary for the optimal expansion of
effector CD8+ T cells. Time course showing the percentage of Ova/Kb-specific
CD8+ T cells (A) and B8R/Kb-specific CD8+ T cells (B) from the blood in mixed
bone marrow chimera mice infected with 103 CFU of LM-ova or 2 × 106 PFU
of VV-WR, respectively. The CD8+ T cell population was first divided into WT
cells (blue) or CD25-deficient cells (red) and then the percentage of antigen-
specific CD8+ T cells was monitored longitudinally in the blood.
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either day 4 or day 8. One day later, mice were killed and BrdU
incorporation into the splenic Ova/Kb-specific CD8+ T cells was
analyzed. WT and CD25−/− antigen-specific CD8+ T cells in-
corporated similar levels of BrdU from days 4 to 5 of the response
(Fig. 5A), at a time when CD25 expression is being up-regulated.
However, as the peak of the response approached on days 8 and 9,
WT antigen-specific CD8+ T cells incorporated significantly more
BrdU than their CD25-deficient counterparts (Fig. 5B). Thus, in
agreement with earlier studies (32), initial CD8+ T cell expansion
was IL-2 independent, although sustained proliferative expansion
and/or survival required CD25 expression.
CD25-Deficient CD8+ T Cells Retain the Ability to Respond to
Secondary Challenges. To elucidate whether the CD25−/− mem-
ory population was capable of a secondary response, LM-ova
memory mice were restimulated with LM-ova, whereas VV-WR
memory chimeras were challenged with an attenuated LM-B8R.
Although fewer CD25−/− memory cells were present, due to the
reduced primary response, in both infections the CD25−/− CD8+
T cells were able to undergo a robust secondary expansion, which
was similar when compared to WT cells (Fig. 6 A and B).
To further examine the recall potential of the CD25-deficient
pathogen-specific CD8+ T cells, memory CD8+ T cells from
chimeric mice were sorted into CD25−/− (CD45.2+) and WT
(CD45.1+) populations. After sorting, 1,000 Ova/Kb-specific
CD8+ T cells of each were mixed and transferred into naïve
C57BL/6 mice (CD45.1+ CD45.2+). One day after transfer, mice
were challenged with 2 × 103 CFU of LM-ova and 8 days later
the mice were killed and the absolute number of Ova/Kb-specific
CD8+ T cells of CD25−/− and WT origin was enumerated. Both
the WT and CD25-deficient memory cells underwent substantial
secondary expansion, greater than 359-fold (WT) and greater
than 122-fold (CD25−/−) in the spleen, respectively (Fig. 6C).
Furthermore, when the secondary effector cells were divided
based on KLRG1 and CD127 expression, the SLEC population
was depressed within the CD25−/− cells, whereas the EEC and
MPEC subsets were increased, as was observed in the primary
response (Fig. 6C).
Discussion
CD4+ T cell help has been shown to be pivotal for primary or
secondary CD8+ T cell responses in numerous infection models.
However, perplexing discrepancies remain between models as to
the nature of the mechanisms that dictate the level of CD4+ T cell
dependency of a particular response. In addition, the CD4+ T cell
derived factor(s) that provide help to the CD8+ T cells may be
varied. Although CD40-mediated activation of DC may be one
mechanism to promote CD8+ T cell responses, IL-2 production
may also augment the CD8+ T cell response either alone or in
concert with CD40 signaling. For instance, no defect has been
observed for memory CD8+ T cells developing in the absence
of CD40 signaling during LM infection (33). In contrast, CD40
signaling appears to be critical for full differentiation of memory
CD8+ T cells following influenza A virus, murine γ-herpesvirus,
and intranasal vaccinia virus infections (23, 29). Our results
showed that the CD8+ T cell response to i.p. VV infection was
B6
CD25-/-
p = 0.026
0
20
40
60
80
100
%
 B
rd
+ U
A
B
B6
CD25-/-
0
20
40
60
80
100
NS
BrdU
BrdU
B6
B6
CD25-/-
CD25-/-
%
 B
rd
+ U
Fig. 5. CD25-deficient effector CD8+ T cells do not maintain a high pro-
liferative level late in the immune response. Mice were infected with Lm-ova
then treated i.p. with 1mg of BrdU every 12 h either on day 4 (A) or day 8 (B)
and harvested one day later. Representative histograms display BrdU in-
corporation inOva/Kb-specific CD8+T cells and the rightgraph shows themean
± 1 SD for each time point. Statistical significance was determined using a
Student's t test.
A
B Day 7
0
25
50
75
100
SLEC Double
Positive
MPEC Early
Effector
Day 10
0
25
50
75
100
SLEC Double
Positive
MPEC Early
Effector
***
***
Day 24
0
25
50
75
100
*
**
SLEC Double
Positive
MPEC Early
Effector
C
CD25-/-
B6
KLRG1
C
D
1
2
7
Day 11 Day 28Day 6
13.4±3.9 7.8±1.2
54.5±3.924.3±3.5
5.5±2.9 9.6±3.5
77.4±7.07.4±2.4
14.6±4.8 11.6±3.4
47.6±14.526.2±11.3
19.0±3.1 5.6±2.4
47.8±12.127.6±8.6
9.9±4.3 18.3±6.0
71.2±6.44.8±1.7
29.9±8.8 8.5±6.8
48.7±7.09.3±7.3
0
25
50
75
100
%
 o
f 
O
va
/K
b  
po
pu
la
ti
on
%
 o
f 
O
va
/K
 p
op
ul
at
io
n
%
 o
f 
O
va
/K
 p
op
ul
at
io
n
Day 6
SLEC Double
Positive
MPEC Early
Effector
Day 28
0
20
40
60
80
100
SLEC Double
Positive
MPEC Early
Effector
***
***
Day 11
0
25
50
75
100
SLEC Double
Positive
MPEC Early
Effector
**
**
**
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nals. CD25−/− mixed chimera mice were infected with 103 CFU of Lm-ova and
effector CD8+ T cells were monitored in the blood. (A) Representative zebra
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CD40 independent but required CD4+ T cells, IL-2, and CD28-
mediated costimulation (Fig. 1). CD4+ T cells and IL-2 were also
critical for driving normal primary CD8+ T cell responses to LM
and VV-WR infections (Figs. 2 and 3). Interestingly, CD4+ T cell
help and IL-2 were needed relatively late in the primary response
to promote proliferation and perhaps survival because early CD8+
T cell expansion occurred normally in the absence of CD4+T cells
or CD25 but was followed by a more dramatic contraction phase
(Fig. 3). Thus, it is important to consider the overall kinetics of a
response when analyzing potentially controlling factors.
Ourfindings indicated that onemechanismbywhichCD4+Tcells
may provide help was through the control of the up-regulation of
CD25 expression by recently activated CD8+ T cells (Fig. 1). The
decreased CD25 expression could be a direct result of CD28:CD80/
86 signals but might also be a consequence of decreased IL-2 pro-
duction in the absence of CD4+ T cells because IL-2 is known to
regulate CD25 expression (34). Both are likely the case as engage-
ment of theCD28:CD80/86pathway causes IL-2 expression (30) and
the provision rIL-2 in the absence ofCD4+Tcell help resulted in up-
regulationofCD25expression (Fig.S2andref. 34).Eitherway, in the
absence of CD4+ T cells, CD25 was poorly up-regulated on re-
sponding CD8+T cells after VV,VSV, and LM infections. This is in
line with previous studies that have demonstrated that CD4+ T cell
help regulates CD25 expression on CD8+ T cells after HSV-1 in-
fection (35) and DC vaccination (36) and correlated with the CD4+
T cell dependence of these responses. In contrast, previous studies
reported noCD4+T cell orCD25 involvement in the primaryCD8+
T cell response to LCMV and LM infections (18, 19, 27, 28), al-
though other studies support a role for CD4+ T cells in primary
CD8+ T cell responses to these and other immunogens (21, 22).
Interestingly, the route of infectionmay also determine the necessity
of CD4+ T cell help because primary CD8+ T cell responses were
“help” independent whenmice were infected i.n. withVV-WR (23),
but our current study demonstrated the primary response to i.p. in-
fection with VV-WR was dependent on CD4+ T cell help (Fig. 2).
Interestingly, our data indicated that the early CD8+T cell response
was independent of CD4+ T cell help and IL-2, whereas the con-
tinued differentiation and expansion typically required both (Figs. 3
and 5). Whether the necessary IL-2 for sustained CD8+ T cell ex-
pansion is derived solely from CD4+ T cells is not known. Our pre-
vious studies showed that autocrineCD8+Tcellproduced IL-2 isnot
required for maximal expansion but, in fact, appears to dampen the
overall magnitude of the response (32). Furthermore, work by Liv-
ingstone and colleagues demonstrated that CD4+ T cells provided
the major source of IL-2 for responding antigen-specific CD8+ T
cells (26). In either case, CD25 expression would be required to
mediate IL-2effects and thereforeCD4+Tcellswouldbe involved in
the regulation of the CD8+ T cell response at multiple levels.
Recent work illustrates that substantial heterogeneity exists
within the effector CD8+ T cell population. Originally, memory-
precursors were identified by their retention of CD127 ex-
pression (37, 38), which has now been refined to use KLRG1 and
CD127 expression to identify MPEC and SLEC (12–14), and, in
this report, EEC. Only recently have some of the factors regu-
lating the differentiation of the MPEC and SLEC populations
been identified. Although earlier work demonstrated that TCR
or cytokine signaling alone were insufficient to up-regulate
KLRG1 on T cells (39), recent work has shown that IL-12 sig-
naling in the antigen-specific CD8+ T cells is important for
SLEC differentiation and this process is T-bet mediated (12).
Furthermore, inflammatory and IL-12 signaling events are tem-
porally linked with TCR engagement (16). The transcription
factor Blimp1 has been found to be important in the generation
of SLEC (40, 41). Interestingly, Blimp1 expression is regulated
by IL-2 in vitro (42) and our data demonstrated that IL-2
mediated signals played an important role in regulating the
formation of the SLEC population (Fig. 4). Thus, IL-12 likely
mediates early events in the initial differentiation of the SLEC,
although IL-2, perhaps through enhancement of Blimp1 ex-
pression, acts at later times to further promote the differ-
entiation of more SLECs, perhaps from EEC that express the
highest levels of CD25.
Our studies further demonstrated that CD25-deficient pathogen-
specific CD8+ T cells generated an MPEC population during the
effector stage, and these cells went on to form a stable, long-lived
memorypool (Figs. 3 and4).Moreover, in the absence of IL-2 driven
signals, memory CD8+ T cells from LM and VV infected mice re-
sponded vigorously to a secondary challenge (Fig. 6). However,
SLEC development was again dampened just as we observed in the
primary response implicating IL-2 in modulation of the primary and
secondary responses through enhancing the late differentiation of
the SLEC population. Nevertheless, we found little evidence for a
helpless phenotype of memory CD8+ T cells that developed in the
absence of CD4+ T cells or CD25. Previous studies performed with
LCMV-specific P14 TCR transgenic CD8+ T cells lacking CD25
indicate that although cells are capable of proliferating during a
secondary response, their overall accumulation is impaired. The
authors attributed these findings to a potential increase in cell death
(27). In contrast, we observed robust expansion of CD25−/−CD8+T
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Fig. 6. CD25-deficient memory CD8+ T cells are able to mount a robust
secondary response. CD25−/−/WT mixed chimera mice were primed with 103
CFU of LM-ova (A) or 2 × 106 PFU of VV-WR (B) and left for more than 42
days and challenged with 5 × 104 CFU of LM-ova or 106 CFU of LM-B8R,
respectively. Mice were subsequently bled to monitor the magnitude of the
pathogen-specific CD8+ T cell response. Representative dot plots show the
prechallenge frequency of antigen-specific CD8+ T cells and the peak recall
response. The bar graph shows the average expansion of the pathogen-
specific CD8+ T cells at the indicated times and relative fold expansion of
each population. (C) WT (CD45.1+) and CD25−/− (CD45.2+) CD8+ T cells were
purified by flow cytometry and then 1,000 Ova/Kb-specific CD8+ T cells mixed
together and injected i.v. into naïve CD45.1+/CD45.2+ recipient mice. One
day later mice were challenged with 5 × 103 PFU of Lm-ova and the number
of Ova/Kb-specific CD8+ T cells was enumerated in the spleen and lungs on
day 8 postchallenge. Zebra plots are gated on the Ova/Kb-specific CD8+ T
cells of WT or CD25−/− origin and secondary effector cell subpopulations
were determined. Values represent the mean ± 1 SD from four mice and
data are representative of two independent experiments.
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cells during the secondary response at multiple time points. It is
possible that LCMV secondary responses are dependent upon IL-2
signals, although the infectious models we studied are not because
the LCMV results were confirmed by a separate group (28). How-
ever, Williams et al. (27) also observed a defect in recall responses
to LM-ova in experiments that were very similar to our own. Al-
though we cannot explain these discrepancies, the reproducibility of
our results in three separate infection models suggested that im-
printing of proliferative capacity during the primary CD8+ T cell
response for the derived memory cells is not a generalizable phe-
nomenon. Therefore, we conclude that CD4+ T cell help drives
CD25 up-regulation and this in turn allows IL-2 to enhance SLEC
differentiation during both primary and secondary CD8+ T cell re-
sponses, rather than acting as a “programmer” of the downstream
memory response.
Materials and Methods
Mice. All mice were used between 5 and 8 weeks of age for these studies. To
generate mixed bone marrow chimeras, B6-Ly5.2 recipient mice were lethally
irradiatedwith approximately 1,000 rads and subsequently injected i.v. with a
total of 106 bone marrow cells containing a mixture of CD25−/− and B6-Ly5.2
at a 2:1 ratio. Mice were left for at least 50 days before infection. All animal
protocols were approved by the Animal Care Committee at University of
Connecticut Health Center, Farmington, CT, and the Animal Care and Use
Program at Dartmouth College, Hanover, NH.
Experimental Treatment of Mice. Mice were infected with 105 PFU VSV-ova
(i.v.), 103 CFU LM-ova (i.v), or i.p. infection with 2 × 106 VV-WR. For secon-
dary infections VV-WR memory mice were infected i.v. with 1 × 106 CFU of
attenuated (ActA- LLO-) LM expressing the B8R epitope (LM-B8R), whereas
both VSV-ova and LM-ova memory mice were challenged with 5 × 104 CFU
of LM-ova. CD4+ T cells were depleted as previously described (21, 23). To
supply exogenous IL-2, mice were treated with 15,000 U of recombinant
human IL-2 i.p., as previously performed (34).
Tissue Sample Preparation and Flow Cytometric Analysis. Mice were either
bled at the indicated time points or single cell suspensions of the indicated
tissues were prepared by collagenase digestion as previously described (2),
and cells were stained as previously described (1, 23). BrdU incorporation
was analyzed as previously described (1).
Adoptive Transfer and Recall of Memory CD8+ T Cells. WT (CD45.1) and CD25-
deficient (CD45.2) memory CD8+ T cells were sorted on a FACSAria to >98%
purity. 1000 Ova/Kb-specific memory CD8+ T cells from each cell population
weremixed together and injected i.v. intonaïveCD45.1/CD45.2 recipientmice.
One day later mice were challenged with 5 × 103 PFU of LM-ova and the
number of tetramer+ cells was enumerated in the spleen and lungs on day
8 postchallenge.
Statistical Analysis. Statistical significance was determined by a Student's t
test using Prism 5. Significance was set as any P value less than 0.05.
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